Bimeda News

Bimeda Welcomes Ben Siegfried

Bimeda® is pleased to announce the appointment of Ben Siegfried as a Regional Strategic Sales Manager for the states of Nebraska and Iowa. Ben will be an integral part of the livestock sales team and ...

Bimeda Welcomes Tim Blackstone

Bimeda® is pleased to announce Tim Blackstone in the new role of Territory Sales Manager for the Upper Midwest/Plains including the states of North Dakota, South Dakota, Minnesota, and Wisconsin. Tim ...

Bimeda Launches Macrosyn™ (tulathromycin injection) 100 mg/mL, becoming the first available and launched FDA-approved brand alternative Draxxin® in the US.

Bimeda is pleased to announce the launch of Macrosyn (tulathromycin injection) 100mg/mL. Macrosyn is a ready-to-use injectable solution containing 100 mg of tulathromycin/mL, a broad spectrum, fast-ac...

CONGRATULATIONS

We would like to congratulate Stephanie Batliner, Director of Regulatory Affairs of North America, on her election to the role of Chair of GADA (Generic  Animal Drug Alliance). We would like to c...

Bimeda Announces Expanded Marketing Efforts and Packaging Options For Confidence EQ After Product Achieves Notable Marketplace Success

Following consistent growth and popularity of Bimeda® lnc.'s Confidence EQ®, the parent company announced plans to expand marketing efforts and packaging options today for the equine appeasing ph...

Bimeda Biologicals Introduces Dr Paul Lawrence, Research and Development Director

We welcome Dr. Paul Lawrence as the Research and Development Director for Bimeda Biologicals. Dr. Lawrence will manage and provide strategic direction in the development of USDA approved products and ...

Bimeda Welcomes David Christian

Bimeda® is pleased to announce the appointment of David Christian as a Strategic Sales Account Manager for the Livestock Southern Region (Texas, Oklahoma and Eastern New Mexico). David will work as pa...

Bimeda Announces ‘Bimeda Biologicals Inc’ as Name for Acquired Vaccine Company

Bimeda Inc. is pleased to announce the formal renaming of acquired vaccine production, research and diagnostic company, Texas Vet Lab, Inc., as Bimeda Biologicals Inc. Both Texas Vet Lab, Inc. (TVL) a...

Bimeda Welcomes Rey Armendariz

Bimeda® is pleased to announce Rey Armendariz in the new role of Regional Strategic Manager. Effective immediately, Rey will be an integral part of the food animal sales team and assist in the sales d...

Bimeda Launches BimaGard™ 12.5% Liquid Concentrate

Oakbrook Terrace, Illinois (May 6, 2020) – Bimeda®, a growing global manufacturer, marketer and distributor of animal health products, announced today their launch of BimaGard™ 12.5% (tiamulin hydroge...